We’re always looking for ways to innovate and improve our business at TUNECT CRO, so when we heard about ChatGPT, an AI chatbot that can carry on a conversation just like a human, we were intrigued. We decided to put ChatGPT to…
Coincidentally, Alex Rosis began working with us a few days prior to Christmas. It’s a pleasure to have you here this year. A strong business development department is one of the most significant components of the team. We proudly work…
Prior to the COVID-19 pandemic, much research was devoted to the study of gene therapy and, in particular, to adeno-associated virus vector gene therapy. The research was carried out in oncology, hemophilia, and other serious and/or orphan diseases, however, approved…
The FDA has officially approved Elon Musk’s Neuralink chip to proceed with human trials, marking a momentous milestone in the field of neuroscience. This revolutionary brain-computer interface (BCI) technology, developed by Elon Musk’s Neuralink, has the potential to transform the treatment of neurological disorders…
CDISC and their funding partner, the National Organization for Rare Disorders, have announced the public review of version 1.0 of the Rare Diseases Therapeutic Area User Guide (TAUG-Rare Diseases). This guide provides valuable insights and guidance for CDASH, SDTM, and…
We successfully organized and conducted the iDMC for Phase I, Randomized, Double Blind, Placebo-Controlled, Safety, Reactogenicity, and Immunogenicity Trial of the SARS-CoV-2 Vaccine in Healthy Volunteers. This milestone marks a significant step forward in the fight against COVID-19. We have…